Relief Therapeutics Holding AG (RLFTF)

[Bill B]

Acer does have a drug, edsivo, that still has potential but needs funding for further trials according to the FDA. They denied approval but pointed the way forward for potential approval. Acer doesn't have the money to continue the trial and that's potentially where relief might come in. Frankly, after reading about Acers problems I'm surprised they're still listed.

https://ehlersdanlosnews.com/2020/03/26/fda-denies-acers-appeal-for-edsivo-a-potential-vascular-eds-therapy/